|
Amitrole |
CAS 61-82-5 | ||
C2H4N4 |
RTECS XZ3850000 | ||
Synonyms & Trade Names Aminotriazole; 3-Aminotriazole; 2-Amino-1,3,4-triazole; 3-Amino-1,2,4-triazole |
DOT ID & Guide |
Exposure
|
NIOSH REL: Ca TWA 0.2 mg/m3 See Appendix A | ||
OSHA PEL†: none | |||
IDLH Ca [N.D.] See: IDLH INDEX | Conversion |
Physical Description Colorless to white, crystalline powder. [herbicide] [Note: Odorless when pure.] |
|||
MW: 84.1 |
BP: ? |
MLT: 318°F |
Sol(77°F): 28% |
VP: <0.000008 mmHg |
IP: ? |
|
Sp.Gr: 1.14 |
Fl.P: NA |
UEL: NA |
LEL: NA |
|
Noncombustible Solid, but may be dissolved in flammable liquids. | |||
Incompatibilities & Reactivities Light (decomposes), strong oxidizers [Note: Corrosive to iron, aluminum & copper.] |
Measurement Methods NIOSH 0500; OSHA PV2006 See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Water wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, ingestion, skin and/or eye contact | |
Symptoms Irritation eyes, skin; dyspnea (breathing difficulty), muscle spasms, ataxia, anorexia, salivation, increased body temperature; lassitude (weakness, exhaustion), skin dryness, depression (thyroid function suppression) | |
Target Organs
Eyes, skin, thyroid Cancer Site [in animals: liver, thyroid & pituitary gland tumors] |
See also: INTRODUCTION See ICSC CARD: 0631 |